[1]
Sibanda, O.S. 2017. Comparative analysis of access to patented HIV/AIDS pharmaceutical medicines through the Canadian and EU TRIPS flexibilities measures: are they efficacious or overly burdensome and ineffective measures?. Potchefstroom Electronic Law Journal. 15, 2 (May 2017), 520–552. DOI:https://doi.org/10.17159/1727-3781/2012/v15i2a2498.